microdosing glp 1 for autoimmune GLP-1s: Does It Work? Risks and Benefits The People v. Microdosing GLP-1's
Description
First-time prescribing of GLP-1 receptor agonists from 2018-2023: a descriptive analysis
Access this article Similar content being viewed by others Data Availability Not applicable
The American Society of Anesthesiologists recommends individualized perioperative strategies, including temporary liquid diets for some higher-risk patients
Ultimately, I believe there are certain populations where GLP-1 agonists may be appropriate, beneficial, and promote impactful changes to health
The global rise in obesity, particularly in low- and middle-income countries, poses serious health challenges
The lancet Diabetes & endocrinology , 4 (6), 537-547
